Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Almaden Genomics Integrates Omics Playground with g.nome Platform | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Almaden Genomics Integrates Omics Playground with g.nome Platform

Aims to make true end-to-end analysis attainable.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Almaden Genomics has partnered with BigOmics Analytics to integrate Omics Playground with g.nome, Almaden’s cloud-native omics data science solution to provide end-to-end analysis.
 
While g.nome is designed to facilitate effortless iteration in data processing and analysis, allowing researchers to explore their results with complete traceability and reproducibility, Omics Playground is a data discovery platform that aims to enable researchers to dig deeper with interactive analysis for a better understanding of underlying biology.
 
“Connecting Omics Playground with the g.nome solution gives researchers an easy transition into downstream analysis,” said David Gascoigne, CEO of Almaden Genomics. “The ability to go further downstream with added tertiary analysis further accelerates the researcher’s race toward critical insights.”
 
Swiss-based BigOmics developed Omics Playground to help scientists explore their omics data with an interactive interface, offering intuitive visualization and data exploration modules. Pairing Omics Playground with g.nome simplifies the journey for the data scientist and biologist wanting to streamline drug discovery.
 
“Linking our platform with g.nome allows us to make true end-to-end analysis attainable,” said Murat Akhmedov, Ph.D., Co-founder and CEO at BigOmics. “We aim to democratize omics data analysis, expediting tertiary analysis and enhancing collaboration within biotech and academic teams. Making tools more accessible invites more innovation from all levels by lowering the barriers to discovery.”
 
Almaden Genomics’ g.nome platform is designed to deliver pre-built, transparent, and fully modifiable workflows that enable scientists to unlock results quickly and easily and dig deeper where needed—with a complete understanding of the results and where they came from.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics